Genetics of Childhood Disorders: VI. FISH, FISH, and More FISH
It is perhaps surprising to those not intimately involved in the field of genetics to realizethat the total numbe r of human chromosomes was not clearly establi shed until 1956. However, over the past 43 years, cytogenetics has undergone a spectacular evolution involving both cytological and molecular techniques. A major breakthrough was the development in 1970 of the first chromosomal banding technique, called quini crine banding. This provided the ability to ident ify and enumerate the 46 individual human chromosomes as well as to detect translocations, inversions, regions of amplification, deletions, rearrangements, insertions, and other chromosomal abnormalities. Very quickly, a number of additional banding techniques were developed. Today, Giemsa band ing of metaphase chromosomes is the gold standard for karyotypic analysis.
The advent of recombinant DNA cloning techniques in the mid 1970s provided an approach to identity genes associated with specific genetic disorders. Cloning made available chromosome-specific repetitive DNA probes and single-copy sequence probes that could be hybridized to chromosomes to detect genetic changes at the molecular level.The development of chromosome-specific libraries by flow cytometry, the introduction of nonisotopically labeled probes, and the advent of methods to suppress hybridization signals from ubiquitous, repetitive sequences, rapidly led to high-throughput gene mapping. Furthermore, the development of interphase cytogenetics permitted the analysis for extra chromosomal copies, loss of heterozygosity, and translocations in interphase nuclei as well as metaphase chromosomes.
One of the steps in isolating a gene of interest is to know exactl y where it lies on the human genome. Fluorescence detection methods, which rapidly superseded isotopic detection, are the most sensitive and efficient means for detecting hybridized probes. Fluorescence in situ hybridization (FISH) of single-sequence probes is used today for clinical testing as well as for research (Fig. 1A) . Increasingly, clinical cytogenetic laboratories are using disease-specific FISH probes in confirrnational cytogenetic screening for many microdeletion syndromes with recognizable phenotypes, e.g., cri-du-chat, DiGeorge, and Williams syndromes.
FISH has become an essential element in positional cloning strategies by providing a bridge between 2 data sets: the clinical data on patients with characteristic cytogenetic abnormalities and the information on the physical organization of rhe human genome derived from the human genome project. The approximate position of a chromosomal abnormality in a patient is first described by cyrogenetic band or by the distance from the p telomere. Using public databases that are now available at a touch of a personal computer, human genomic DNA clones are identified that have a similar physical location and known genetic linkage association, providing the options of testing patient DNA by analysis of neighboring genetic linkage markers or using genomic DNA clones for further testing of patient chromosomes by FISH.
These technologies have led to an intensive search for characteristic chromosomal changes in individuals with neuropsychiatric disorders. The search for the gene(s) within microdeletion syndrome regions has been successful in several cases. For example, Williams syndrome is now known to result from a deletion on chromosome 7, while Angelman and Prader-Willi syndromes are most often caused by deletions on chromosome 15. It is likely that most neuropsychiatric disorders are due to single-base mutations that are undetectable by in situ techniques . However, even a single translocation case can lead to the identification of the disease-causing gene through the identification of clones mapping to the translocation breakpoint. This permits subsequent mutation analysis of patients with no detectable cytogenetic abnormality. Reported chromosomal changes seen in individuals with autism include small duplications (Xp22.3-22.2), small deletion (lq43), and larger deletions (5qI5-q22.3 or 18q). There is an increased incidence of autism in individuals with 15ql1.2-q13 duplications (Prader-Willi region). Molecular analysis of such breakpoints has not yet led to the identification of an autism gene, although this is being pursued in severallaboratories. Similarly, an increased incidence of schizophrenia has been reported to be associated with abnormalities on X chromosome as well as with a variety of autosomal rearrangements.
Another advantage of FISH is that severalspeerrally distiner fluorophores can be used simultaneously. By hybridizing sets of chromosome-specific DNA probes, each labeled with a different combination of fluorescent dyes, it is possible to ascribe to each chromosome a unique spectral signature or identifier tag (Fig. 18) . Only 5 fluorophores were needed to distinguish the . 24 different human chromosomes. A banding probe labeled DEVELOPMENT AND NEUROBIOLOGY with a sixth fluorophore can be used to give banding profiles similar to Giemsa. Karyotyp ing by color has been shown to detect chromosomal abnormalities that are difficult or impossible to identify by Giemsa banding.
An alternative use of multiple fluors is that demonstrated by Lignon and coworkers. They developed a probe set for 4 common deletion regions: Prader-Willi and Angelman, Williams, Smith-Magenis, and DiGeorge/velocardiofacialsyndromes. Ten of 46 caseswere found to have one of these microdeletions.
Recent advanceshave described the development of telomerespecific probes that can identify previously undetectable rearrangements at the tips of chromosomes, termed telomeric translocations or deletions. A number of retardation disorders including the ATF-16 syndrome, cri-du-chat, Wolf-Hirschhorn, and Miller-Dieker syndromes may result from telomere translocation or subtelomeric deletions.
The recognition that telomere translocations or deletions might be a frequent cause of mental retardation led to a key study carried out by Flint and colleagues that addressed the question of what percentage of mentally retarded patients with apparently normal karyotypes will show cryptic translocations and whether these translocations are frequent in the nonretarded population. They used 3 dozen variable number tandem repeat (VNTR) probes to examin e 28 (of 48 possible) subtelomeric regions. They studied 99 patients with varying degrees of idiopathic mental retardation and apparently normal karyotypes. Three of the patients had telomere monosomy, 1 on chromosome 13 and 2 on chromosome 22. Two of the cases of monosomy resulted from unbalanced translocations, and 1 resulted from an interstitial or terminal deletion. Considering that only half the telomeres >yere surveyed and that many of the alleles were noninformative, they estimated the percentage of cryptic subtelomeric monosomy in retarded individuals to be 6% (95% confidence limits are 1.2%-17.6%). In a survey to determine the rate of telomere monosomy of chromosome 13 and chromosome 22 telorneres in normal individuals, no rearrangements were found in more th an 160 nuclear families with 1,000 individuals tested. Recently, by use of one additional hypervariable polymorphic probe using the same patient population, they identified an additional telomeric deletion, bringing the current estimate of frequency of unbalanced telomeric rearrangements to slightly more than 7%. These observations strongly suggest that cryptic translocations are a major contributor to the mental retardation phenotype, yet this possibility has not been rigorously examined.
The recent development of M-FISH and multiplex telomere screening assays provides a novel opportunity to definitively establish the role of cryptic translocations and subtelomeric deletions in the etiology of mental retardation and other childho od neuropsychiatric diseases. Are there discrete classes of genomic rearrangements associated with certain subpopulations of affected individuals? How many different types of cryptic translocations or deletions are associated with neuropsychiatric disorders? Are they chromosomally clustered or distributive? Although severalhundred genes have been postulated to contribute to the mental retardation phenotype, only a limited number have been actually identified. The new molecular cytogenetic tools that have emerged within the past few years perm it the exploration of these patient populations in a fashion previously unattainable. 0890-8567/99/ 3809-1200©199 9 by the American Academy of Ch ild and Adolescent Psychiatry.
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